What is Orthokine (Regenokine) therapy?

Orthokine (or Regenokine in the USA) is a procedure in which a patient’s blood is extracted, manipulated and reintroduced into the body as an anti-inflammatory drug to reduce chronic pain and osteoarthritis.

The therapy is used for meniscus tear treatment, as cell therapy for arthritis, torn ACL and to treat MCL cartilage damage caused by sports injuries. It is a way of treating these injuries and chronic pain without drugs or foreign substances. The method is biological and makes use of the body’s own proteins and healing factors.

What is the procedure for Orthokine therapy?

Blood is drawn from the patient’s vein and processed under special conditions. The blood is incubated at 37 degrees to stimulate the production of the anti-inflammatory protein Interleukin-1-receptor (IL-1Ra). The protein is extracted in a laboratory and filled in ampoules, later available in injection form.

The serum that has been obtained is re-injected into the area of pain on the patient, such as the joints. The injections are given one to two times a week and patients are advised to avoid strenuous exercise for 48 hours.

What are the advantages of Orthokine therapy?

The benefits of using Orthokine therapy include:

• very rare side effects
• anti-inflammatory
• regenerative
• reduces pain
• improves mobility
• long-term benefit
   

How long do the effects of Orthokine therapy last?

Every case depends on the individual patient and will last a different length of time. The severity of the injury will determine the length of the results. The healing process begins immediately upon delivery of cells to the body. The effectiveness of the treatment will depend on the patient’s ability to follow post treatment care, which involves extensive rehabilitation to strengthen areas that were affected.